Dysregulation of MicroRNAs in Adult Osteogenesis Imperfecta: The miROI Study
Authors' conclusion
This is the first study to establish the miRNA signature in OI, showing a significant modification of miRNA expression potentially involved in the regulation of genes involved in the physiopathology of OI.
Study context
- Population
- Adults with osteogenesis imperfecta; serum circulating micro-RiboNucleic Acids (miRNAs)
- Comparison
- Adults with osteogenesis imperfecta (OI) vs controls
- Outcome
- Circulating miRNAs differentially expressed in OI vs controls, potentially associated with OI severity
Methodological detailsthree-phase design, RNA sequencing screening, RT-qPCR validation
- Three-phase design
- RNA sequencing screening
- RT-qPCR validation
Main finding
As reported in the abstract
Circulating miRNA expression in serum
Phase 1 (RNA sequencing): miRNAs significantly differentially expressed
79
Selected as most relevant
19
Phase 2 (RT-qPCR, larger OI group): miRNAs with validated significant overexpression
8
Observational data: associations, not effects.
Further findings
Validated miRNAs and clinical characteristics of OI
- miRNAs with significantly different expression in patients with dentinogenesis imperfecta
- 2
Literature review and miRNA-gene interaction prediction
- Validated miRNAs already known to act directly on bone homeostasis
- 6 of the 8
- Confirmed miRNAs with 100% probability of interaction with COL1A1 and/or COL1A2
- 2 of the 8
Original publication
Dysregulation of MicroRNAs in Adult Osteogenesis Imperfecta: The miROI Study. J Bone Miner Res. Published 2 October 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →